TipRanks
Go Ultimate55% OFF

Lipocine (LPCN) Stock Forecast & Price Target

937 Followers
See the Price Targets and Ratings of:

LPCN Analyst Ratings

Hold
1Ratings
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to Lipocine in the past 3 months

LPCN Stock 12 Month Forecast

$4.00â–²(177.78% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Lipocine in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 177.78% change from the last price of $1.44.
Highest Price Target$4.00Average Price Target$4.00Lowest Price Target$4.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for LPCN
Price TargetFollowArticle
H.C. Wainwright$4hold177.78%UpsideReiterated09/22/26
Alliance Global Partners$6buy316.67%UpsideReiterated08/05/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lipocine

3 Months
Scott Henry
Scott HenryAlliance Global Partners
Success Rate1/7 ratings generated profit
14%
Average Return
-18.90%

Copying Scott Henry's trades and holding each position for 3 Months would result in 14.29% of your transactions generating a profit, with an average return of -18.90% per trade.

1 Year
Scott Henry
Scott HenryAlliance Global Partners
Success Rate1/7 ratings generated profit
14%
Average Return
-23.06%

Copying Scott Henry's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -23.06% per trade.

2 Years
Scott Henry
Scott HenryAlliance Global Partners
Success Rate0/7 ratings generated profit
0%
Average Return
-51.24%

Copying Scott Henry's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -51.24% per trade.

LPCN Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for LPCN
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy11110
Buy00000
Hold00111
Sell00000
Strong Sell00000
total11221

In the current month, LPCN has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. LPCN average Analyst price target in the past 3 months is 4.00.

LPCN Financial Forecast

LPCN Stock Forecast FAQ

What is LPCN’s average 12-month price target, according to analysts?
Based on analyst ratings, Lipocine’s 12-month average price target is $4.00.
What is LPCN’s upside potential, based on the analysts’ average price target?
Lipocine has 177.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LPCN a Buy, Sell or Hold?
Lipocine has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Lipocine’s price target?
The average price target for Lipocine is $4.00. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00, the lowest forecast is $4.00. The average price target represents a 177.78% increase from the current price of $1.44.
What do analysts say about Lipocine?
Lipocine’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of LPCN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.